← Open Payments lookup

MARLO HARGRAVE: Open Payments

NPI 1275041923 · NEWPORT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,019 in 64 payments from 15 companies in 2025. Trend: 2023 $477 · 2024 $648 · 2025 $1,019

Food & beverage: $1,019
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$284
ABBVIE INC.17$184
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$145
E.R. Squibb & Sons, L.L.C.2$140
Novo Nordisk Inc2$43
Lundbeck LLC2$34
GlaxoSmithKline, LLC.2$34
Lilly USA, LLC2$31
Amgen Inc.2$29
Abbott Laboratories1$23

Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, Ozempic, TRELEGY ELLIPTA, MOUNJARO, FREESTYLE LIBRE 3.

Industry payments across AR — which companies pay providers there.